These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 20426802)

  • 21. Metabolic syndrome and risk factors for non-alcoholic fatty liver disease.
    Souza MR; Diniz Mde F; Medeiros-Filho JE; Araújo MS
    Arq Gastroenterol; 2012; 49(1):89-96. PubMed ID: 22481692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome.
    Lim JS; Mietus-Snyder M; Valente A; Schwarz JM; Lustig RH
    Nat Rev Gastroenterol Hepatol; 2010 May; 7(5):251-64. PubMed ID: 20368739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic and therapeutic implications of the association between ferritin level and severity of nonalcoholic fatty liver disease.
    Valenti L; Dongiovanni P; Fargion S
    World J Gastroenterol; 2012 Aug; 18(29):3782-6. PubMed ID: 22876027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathophysiological similarities and synergisms in alcoholic and non-alcoholic steatohepatitis.
    Hellerbrand C
    Dig Dis; 2010; 28(6):783-91. PubMed ID: 21525763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histopathology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Brown GT; Kleiner DE
    Metabolism; 2016 Aug; 65(8):1080-6. PubMed ID: 26775559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron overload in nonalcoholic steatohepatitis.
    Fujita N; Takei Y
    Adv Clin Chem; 2011; 55():105-32. PubMed ID: 22126026
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Babini M
    Minerva Cardioangiol; 2006 Apr; 54(2):229-39. PubMed ID: 16778754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic fatty liver disease and the metabolic syndrome.
    Marchesini G; Marzocchi R; Agostini F; Bugianesi E
    Curr Opin Lipidol; 2005 Aug; 16(4):421-7. PubMed ID: 15990591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A role for low hepatic copper concentrations in nonalcoholic Fatty liver disease.
    Aigner E; Strasser M; Haufe H; Sonnweber T; Hohla F; Stadlmayr A; Solioz M; Tilg H; Patsch W; Weiss G; Stickel F; Datz C
    Am J Gastroenterol; 2010 Sep; 105(9):1978-85. PubMed ID: 20407430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonalcoholic fatty liver disease and HIV infection.
    Merriman RB
    Curr HIV/AIDS Rep; 2006 Sep; 3(3):113-7. PubMed ID: 16970837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Emerging Targets to Relieve Fat Stress-Induced Liver Diseases: UDCA, Tocotrienol, ω-3 PUFAs, and IgY Targeted NPC1L1 Cholesterol Transporter.
    Cha JY; Park JM; Lee HJ; Bae JS; Han YM; Oh BC; Ko KH; Hahm KB
    Curr Pharm Des; 2017; 23(27):3941-3951. PubMed ID: 28714405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonalcoholic fatty liver disease: from pathogenesis to patient care.
    Perlemuter G; Bigorgne A; Cassard-Doulcier AM; Naveau S
    Nat Clin Pract Endocrinol Metab; 2007 Jun; 3(6):458-69. PubMed ID: 17515890
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
    Bosserhoff A; Hellerbrand C
    Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The impact of obesity on liver histology.
    Goodman ZD
    Clin Liver Dis; 2014 Feb; 18(1):33-40. PubMed ID: 24274863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?
    Asrih M; Jornayvaz FR
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():55-65. PubMed ID: 25724480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-alcoholic fatty liver disease.
    Smith BW; Adams LA
    Crit Rev Clin Lab Sci; 2011; 48(3):97-113. PubMed ID: 21875310
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional proteomic analysis of nonalcoholic fatty liver disease in rat models: enoyl-coenzyme a hydratase down-regulation exacerbates hepatic steatosis.
    Zhang X; Yang J; Guo Y; Ye H; Yu C; Xu C; Xu L; Wu S; Sun W; Wei H; Gao X; Zhu Y; Qian X; Jiang Y; Li Y; He F
    Hepatology; 2010 Apr; 51(4):1190-9. PubMed ID: 20162621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.
    Syn WK; Teaberry V; Choi SS; Diehl AM
    Semin Liver Dis; 2009 May; 29(2):200-10. PubMed ID: 19387919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
    Li ZZ; Berk M; McIntyre TM; Feldstein AE
    J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.